Oncotarget

Vol 9, No 92

November 23, 2018

View Archive »

Order a Reprint

About The Cover

The cover for issue 92 of Oncotarget features Figure 4, "Intratumoral CD56bright NK cells are more functional than CD56dim NK cells and correlate with survival in bladder cancer," by Mukherjee, et al.

Table of Contents

News

Chaperoning skin atrophy

Chaperoning skin atrophy

https://doi.org/10.18632/oncotarget.26375

Donald B. DeFranco
36407-36408
PDF  |  Order a Reprint

Editorial

p53 limits B cell receptor (BCR) signalling: a new role for miR-34a and FOXP1

p53 limits B cell receptor (BCR) signalling: a new role for miR-34a and FOXP1

https://doi.org/10.18632/oncotarget.26376

Katerina Cerna,  and Marek Mraz
36409-36410
PDF  |  Order a Reprint

Epstein-Barr virus: From kisses to cancer, an ingenious immune evader

Epstein-Barr virus: From kisses to cancer, an ingenious immune evader

https://doi.org/10.18632/oncotarget.26381

Pankaj Trivedi, Frank J. Slack,  and Eleni Anastasiadou
36411-36412
PDF  |  Order a Reprint

Research Papers

Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation

Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation

https://doi.org/10.18632/oncotarget.26326

Kathleen I. Pishas,  and Stephen L. Lessnick
36413-36429
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Lect2 deficiency is characterised by altered cytokine levels and promotion of intestinal tumourigenesis

Lect2 deficiency is characterised by altered cytokine levels and promotion of intestinal tumourigenesis

https://doi.org/10.18632/oncotarget.26335

Kirsty R. Greenow, Matthew Zverev, Stephanie May, Howard Kendrick, Geraint T. Williams, Toby Phesse,  and Lee Parry
36430-36443
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer

Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer

https://doi.org/10.18632/oncotarget.26342

Giovanny Rodríguez-Blanco, Lona Zeneyedpour, Diederick Duijvesz, A. Marije Hoogland, Esther I. Verhoef, Charlotte F. Kweldam, Peter C. Burgers, Peter Sillevis Smitt, Chris H. Bangma, Guido Jenster, Geert J.L.H. van Leenders, Lennard J.M. Dekker,  and Theo M. Luider
36444-36456
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Oncostatin M is overexpressed in skin squamous-cell carcinoma and promotes tumor progression

Oncostatin M is overexpressed in skin squamous-cell carcinoma and promotes tumor progression

https://doi.org/10.18632/oncotarget.26355

Marie Simonneau, Eric Frouin, Vincent Huguier, Cynthia Jermidi, Jean François Jégou, Julie Godet, Anne Barra, Isabelle Paris, Pierre Levillain, Sevda Cordier-Dirikoc, Nathalie Pedretti, François Xavier Bernard, Jean Claude Lecron, Franck Morel,  and Laure Favot
36457-36473
Abstract  |  PDF  |  HTML  |  Order a Reprint

Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells

Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells

https://doi.org/10.18632/oncotarget.26356

Valentina Flamini, Ed Dudley, Wen G. Jiang,  and Yuxin Cui
36474-36491
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Intratumoral CD56bright natural killer cells are associated with improved survival in bladder cancer

Intratumoral CD56bright natural killer cells are associated with improved survival in bladder cancer

https://doi.org/10.18632/oncotarget.26362

Neelam Mukherjee, Niannian Ji, Vincent Hurez, Tyler J. Curiel, Maureen O. Montgomery, Andrew J. Braun, Marlo Nicolas, Marcela Aguilera, Dharam Kaushik, Qianqian Liu, Jianhua Ruan, Kerri A. Kendrick,  and Robert S. Svatek
36492-36502
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Establishment of a novel cell line from a rare human duodenal poorly differentiated neuroendocrine carcinoma

Establishment of a novel cell line from a rare human duodenal poorly differentiated neuroendocrine carcinoma

https://doi.org/10.18632/oncotarget.26367

Kazuyoshi Yanagihara, Takanori Kubo, Keichiro Mihara, Takeshi Kuwata, Atsushi Ochiai, Toshio Seyama,  and Hiroshi Yokozaki
36503-36514
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Glyoxalase 1 gene is highly expressed in basal-like human breast cancers and contributes to survival of ALDH1-positive breast cancer stem cells

Glyoxalase 1 gene is highly expressed in basal-like human breast cancers and contributes to survival of ALDH1-positive breast cancer stem cells

https://doi.org/10.18632/oncotarget.26369

Shoma Tamori, Yuka Nozaki, Hitomi Motomura, Hiromi Nakane, Reika Katayama, Chotaro Onaga, Eriko Kikuchi, Nami Shimada, Yuhei Suzuki, Mei Noike, Yasushi Hara, Keiko Sato, Tsugumichi Sato, Kouji Yamamoto, Takehisa Hanawa, Misa Imai, Ryo Abe, Atsushi Yoshimori, Ryoko Takasawa, Sei-Ichi Tanuma,  and Kazunori Akimoto
36515-36529
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Limitations of current in vitro models for testing the clinical potential of epigenetic inhibitors for treatment of pediatric ependymoma

Limitations of current in vitro models for testing the clinical potential of epigenetic inhibitors for treatment of pediatric ependymoma

https://doi.org/10.18632/oncotarget.26370

Hazel Anne Rogers, Rebecca Chapman, Holly Kings, Julie Allard, Jodie Barron-Hastings, Kristian W. Pajtler, Martin Sill, Stefan Pfister,  and Richard Guy Grundy
36530-36541
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Corrections

Correction: Se2Mo10V3, a heteropoly compound containing selenium, inhibits tumor growth

Correction: Se2Mo10V3, a heteropoly compound containing selenium, inhibits tumor growth

https://doi.org/10.18632/oncotarget.26408

Hong-Ning Zhang, Wei-Li Feng, Chun-Na An,  and Wen-Guang Li
36542-36542
Correction  |  PDF


Copyright © 2018 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC